A Nature Neuroscience study reports that tau aggregates can trigger neuronal death through a mechanism involving Z-RNA, offering a potential new target area for therapies in tauopathies. Researchers described how tau aggregation leads to toxicity pathways that culminate in neuronal loss, linking disease pathology to RNA species that form under specific conditions. The findings add to the growing shift from viewing tau pathology as only a protein aggregation problem toward mapping downstream molecular drivers that could be druggable. While therapeutic translation was not detailed in the prompt, the study provides a defined mechanistic link that can guide target validation and screening. For drug developers, the work points toward interventions that disrupt tau-triggered Z-RNA pathways rather than only focusing on aggregate clearance.